A detailed history of Kbc Group Nv transactions in Enovis Corp stock. As of the latest transaction made, Kbc Group Nv holds 1,708 shares of ENOV stock, worth $51,222. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,708
Previous 2,587 33.98%
Holding current value
$51,222
Previous $99,000 45.45%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

SELL
$29.65 - $37.35 $26,062 - $32,830
-879 Reduced 33.98%
1,708 $54,000
Q1 2025

Apr 25, 2025

BUY
$35.51 - $47.99 $994 - $1,343
28 Added 1.09%
2,587 $99,000
Q4 2024

Jan 22, 2025

BUY
$38.5 - $49.33 $29,568 - $37,885
768 Added 42.88%
2,559 $112,000
Q2 2024

Jul 17, 2024

BUY
$44.56 - $62.43 $28,295 - $39,643
635 Added 54.93%
1,791 $81,000
Q1 2024

May 08, 2024

BUY
$55.44 - $63.8 $26,278 - $30,241
474 Added 69.5%
1,156 $72,000
Q4 2023

Feb 13, 2024

BUY
$43.67 - $57.07 $29,782 - $38,921
682 New
682 $38,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $1.62B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.